Prevalence and Antimicrobial Resistance Profile of Campylobacter Spp. Isolated from Conventional and Antimicrobial-Free Swine Production Systems from Different U.S. Regions
- 1 March 2011
- journal article
- research article
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 8 (3) , 367-374
Abstract
We conducted a study to compare the prevalence and antimicrobial resistance profile of Campylobacter isolated from 34 farm-slaughter pair cohorts of pigs raised in conventional and antimicrobial-free (ABF) production systems. Isolates originated from four different states of two geographic regions (region 1—Ohio and Michigan; region 2—Wisconsin and Iowa). A total of 838 fecal and 1173 carcass samples were examined. Campylobacter isolates were speciated using multiplex polymerase chain reaction targeting ceuE and hipO genes. The minimum inhibitory concentration was determined using agar dilution to a panel of six antimicrobials: chloramphenicol, erythromycin, gentamicin, ciprofloxacin, nalidixic acid, and tetracycline. Campylobacter spp. was isolated from 472 of 838 pigs (56.3%). Campylobacter prevalence did not vary significantly based on production system (conventional [58.9%] and ABF [53.7%], odds ratio [OR] 1.4, 95% confidence interval [CI] 0.8–2.6, p = 0.24) or geographic region (region 1 [54.1%] and region 2 [58.2%], OR 1.02, 95% CI 0.6–1.9, p = 0.92). At slaughter plant, Campylobacter prevalence varied based on processing stages (19.4% at pre-evisceration, 25.3% at postevisceration, and 3.2% at postchill). Resistance was common to tetracycline (64.5%), erythromycin (47.9%), and nalidixic acid (23.5%). Campylobacter isolates from conventional production systems were more likely to be erythromycin resistant than from ABF (OR 3.2, 95% CI 1.4–7.2, p = 0.01). The proportion of ciprofloxacin-resistant Campylobacter coli isolates were 3.7% and 1.2% from ABF and conventional production systems, respectively. Thirty-seven out of 1257 C. coli (2.9%) were resistant to both erythromycin and ciprofloxacin, drugs of choice for treatment of invasive human campylobacteriosis. The finding of ciprofloxacin resistance, particularly from ABF herds, has significant implications on the potential role of risk factors other than mere antimicrobial use for production purposes.Keywords
This publication has 42 references indexed in Scilit:
- Prevalence and patterns of antimicrobial resistance in Campylobacter spp isolated from pigs reared under antimicrobial-free and conventional production methods in eight states in the Midwestern United StatesJournal of the American Veterinary Medical Association, 2010
- Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coliJournal of Medical Microbiology, 2008
- Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in The Netherlands: an overview of 2000–2004Clinical Microbiology and Infection, 2007
- Campylobacter Antimicrobial Drug Resistance among Humans, Broiler Chickens, and Pigs, FranceEmerging Infectious Diseases, 2007
- Isolation of Campylobacter spp. from a pig slaughterhouse and analysis of cross-contaminationInternational Journal of Food Microbiology, 2006
- Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in BacteriaClinical Microbiology Reviews, 2006
- Campylobacter coli: prevalence and antimicrobial resistance in antimicrobial-free (ABF) swine production systemsJournal of Antimicrobial Chemotherapy, 2005
- WHY AND HOW ANTIBIOTICS ARE USED IN SWINE PRODUCTIONAnimal Biotechnology, 2002
- Comparison of excision and swabbing sampling methods to determine the microbiological quality of swine carcass surfacesFood Microbiology, 1999
- Food-Related Illness and Death in the United StatesEmerging Infectious Diseases, 1999